Teh-Ia Huo is an expert in Hepatology at Taipei Veterans General Hospital (Taiwan). As of October 2026, ScienceLeadR ranks Teh-Ia Huo in the top 1% of experts worldwide for Liver Neoplasms and Carcinoma. Teh-Ia Huo has authored 391 publications, the most recent in 2026. SLR score: 1,260 (community average: 125). How the SLR is computed.

LeadR Profile

1 260 ScienceLeadR Reputation 1260
Network Map

Hepatology

Subspecialties: Gastroenterology - Oncology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1989 - 2026

Source: PubMed

Taipei Veterans General Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 391

Citations

Citations: 10 683 1st author: 131 Last author: 82 Unique author: 3


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Immunotherapy-combined chemotherapy as first-line treatment for stage IIIB/IV large cell neuroendocrine lung carcinoma.
PMID 42769200 — cells, lung, drug therapy, immunotherapy, neuroendocrine cells, therapeutics, chemotherapy
Am J Transl Res20260
CATS-BIT-ME Score: A Machine Learning and Conventional Risk Model for Prognosis in Hepatocellular Carcinoma.
PMID 42725053 — carcinoma, hepatocellular, biomarkers, machine learning, learning, prognosis
Gastro Hep Adv20260
MemSAM-2.5D: overcoming volumetric discontinuity and boundary ambiguity for 3D liver tumor segmentation.
PMID 42488108 — carcinoma, hepatocellular, neoplasms, multiple chronic conditions, liver
Front Oncol20260
Correction: Chang et al. Improvement of Carbon Tetrachloride-Induced Acute Hepatic Failure by Transplantation of Induced Pluripotent Stem Cells Without Reprogramming Factor c-Myc. Int. J. Mol. Sci. 2012, 13, 3598-3617.
PMID 42353360 — genes, myc, cells, microscopy, electron, scanning transmission, pluripotent stem cells, stem cells, induced pluripotent stem cells, liver failure, acute, carbon tetrachloride, transplantation, liver failure
Int J Mol Sci20260
Evaluating liver reserve in direct-acting antiviral-treated hepatitis C patients: do we have better surrogate markers?
PMID 42014450 — hepatitis c, liver, antiviral agents, hepatitis
J Gastroenterol20260

LeadR Networks

Main global connection map